Damage Control in Abdominal Trauma

Similar documents
Plumbing 101:! TXA and EMS! Jay H. Reich, MD FACEP! EMS Medical Director! City of Kansas City, Missouri/Kansas City Fire Department!

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

Dr Anne Weaver London s Air Ambulance CODE RED THE BLEEDING PATIENT

HEMS in an urbansetting. Anne Weaver RESUS 2013, Limerick 27 th April 2013

United States Department of Transportation National Highway Traffic Safety Administration Paramedic: National Standard Curriculum 1

New Anticoagulants: When and Why Should I Use Them? Disclosures

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy

To assist clinicians in the management of minor, major, and/or life-threatening bleeding in patients receiving new oral anticoagulants (NOACs).

Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services

PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS

Disclosure. Outline. Objectives. I have no actual or potential conflict of interest in relation to this presentation.

Chapter 6. Hemorrhage Control UNDER FIRE KEEP YOUR HEAD DOWN

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August Anticoagulants

- Lessons from SHOT Haemorrhage cases

Session Number 405 CERTIFICATION REVIEW: HEMATOLOGY AND IMMUNOLOGY

Disclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

Transfusion Medicine

Platelet Review July Thomas S. Kickler M.D. Johns Hopkins University School of Medicine

DVT/PE Management with Rivaroxaban (Xarelto)

Joint Theater Trauma System Clinical Practice Guideline

Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery

Recommendations: Other Supportive Therapy of Severe Sepsis*

Aehlert: Paramedic Practice Today PowerPoint Lecture Notes Chapter 50: Abdominal Trauma

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

Types of Bariatric Procedures. Tejal Brahmbhatt, MD General Surgery Teaching Conference April 18, 2012

Guideline Statement for the Treatment of Disseminated Intravascular Coagulation

Endoscopic Treatment of Bleeding Peptic Ulcers Panagiotis Katsinelos, MD, PhD

ABThera Open Abdomen Negative Pressure Therapy for Active Abdominal Therapy. Case Series

Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center

Blood products and pharmaceutical emergencies

TRAUMA SURGERY Dr. Michal Cheatham Orlando Regional Health PGY-4

KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE (GEN. ORG.) NURSING AFFAIRS. Scope of Service PEDIATRIC INTENSIVE CARE UNIT (PICU)

How To Teach An Integrated Ultrasound

Consent for Treatment/Procedure Laparoscopic Sleeve Gastrectomy

Trauma anaesthesia and critical care: the post trauma network era

News Release. Media contacts: Ernie Knewitz Tel: Mobile:

New Oral Anticoagulants

Imaging of Thoracic Endovascular Stent-Grafts

STUDY GUIDE 1.1: NURSING DIAGNOSTIC STATEMENTS AND COMPREHENSIVE PLANS OF CARE

Endoscopic therapy for obesity and complications of bariatric surgery

AVANCOS no TRATAMENTO da HEMORRAGIA MACICA

Sepsis: Identification and Treatment

SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Rivaroxaban A new oral anti-thrombotic Dr. Hisham Aboul-Enein Professor of Cardiology Benha University 12/1/2012

Cirrhosis and Coagulation A Paradigm of Awareness Robert G. Gish MD

Chapter 16. Learning Objectives. Learning Objectives 9/11/2012. Shock. Explain difference between compensated and uncompensated shock

MANAGING BLEEDING IN THE

IVTMTM Intravascular Temperature

Clinical Guideline N/A. November 2013

Critical Bleeding Reversal Protocol

ABOUT XARELTO CLINICAL STUDIES

Cancer and the Heparins

Elisabetta Toso, MD Dipartment of Medical Sciences University of Turin

Directed to Dr. Carrier from NBRHC audience Q: In patients with GI Bleed history, would you suggest Apixaban for newly diagnosed patients

INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS

Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives

Patient Blood Management Guidelines: Module 4. Critical Care

Policies and Procedures. Related to. IABP Therapy

Benefit Criteria to Change for Hyperbaric Oxygen Therapy for the CSHCN Services Program Effective November 1, 2012

Open Ventral Hernia Repair

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl

Gruppo di lavoro: Malattie Tromboemboliche

Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY

Point-of-care testing Thrombelastography and platelet transfusion

Thrombin Formation for Children on Lovenox. Steven Ignell, BA

Hemostasis analyzer system

Advances in Trauma Resuscitation: Implications for the Nurse Anesthetist

USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN)

Conserva)ve Treatment of PE/ DVT

New anticoagulants: Monitoring or not Monitoring? Not Monitoring

Role of the Medical Director

All trauma centers must participate in the state and/or regional trauma system planning, development, or operation.

Adult Inpatient/Emergency Department Procoagulant Clinical Practice Guideline (CPG) Cover Sheet

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

Definitive Surgical Trauma Care-DSTC

APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES

Gastrointestinal bleeding

Surgical Site Infection Prevention

Recommendations on Use of Dabigatran in Atrial Fibrillation

Non-surgical treatment of severe varicose veins

TITLE 836 INDIANA EMERGENCY MEDICAL SERVICES COMMISSION. ARTICLE 1.5 Trauma Field Triage and Transport Destination Requirements

Clinical Study Synopsis

Guidelines for diagnosis and management of acute pulmonary embolism

Improving Appropriate Use of Proton Pump Inhibitors as Gastrointestinal Prophylaxis in the Hospital Setting

Transcription:

Damage Control in Abdominal Trauma Steven Stylianos, MD Surgeon-in-Chief, Morgan Stanley Children s Hospital Rudolph Schullinger Professor of Surgery, Columbia University College of Physicians & Surgeons

Background NOM successful in children with severe solid organ injuries (>88% NOM in Grade IV) JPS 2000; 2002; 2008 Most failures within 6-12 hours J Trauma 2005; 2006 The challenge of teaching psychomotor skills for hemostasis of solid organ injury J Trauma 2009

Time to OR Pediatric Solid Organ Injury 1818 pts (7 PTC; 1997-2002) 89 pts (5%) to OR Median time to OR: 3 hrs 59% within 4 hrs 76% within 12 hrs 1813 pts (NTDB; 1991-2003) 120 pts (7%) to OR Median time to OR: 2.4 hrs 79% within 6 hrs 90% within 24 hrs» J Trauma 2005» J Trauma 2006

% Impact of Guidelines?

Damage Control Definition Rapid hemostasis (ligation, stenting, packing, fixation) Control contamination Temporary abdominal wall closure Resuscitation in ICU

Damage Control Single GSW to Lt 6 th ICS in Dallas, 1963 Diaphragm Spleen Stomach Pancreas Aorta/SMA IVC Rt Kidney Liver

Damage Control? 107 minutes in OR Scoop and run EBL: 6000 ml 16 units PRBC 4 liters RL Temp? Coags? ph? trauma was too great for resuscitation

Damage Control Topics When / How / Where? Hemorrhage Physiology Abdominal Wall

Damage Control Topics When / How / Where? Hemorrhage Physiology Abdominal Wall

Damage Control When? Increased emphasis on physiologic/metabolic state Triad of hypothermia, acidosis, and coagulopathy Success of damage control depends on decision prior to irreversible shock Damage control represents advanced surgical care!

Damage Control Strategy How? - 3 Phases Phase 1 Phase 2 Abbreviated laparotomy Control of hemorrhage and contamination Packing and temporary abdominal wall closure Aggressive ICU resuscitation Core re-warming Optimize volume/o 2 delivery Correct coagulopathy

Damage Control Strategy Phase 3 Planned re-operation for packing change and washout Definitive repair of injuries Abdominal wall closure

Damage Control Where? Any hospital; Battlefield Facilitates transfer Trauma ICU Interventional radiology ERCP

Damage Control Topics When / How / Where? Hemorrhage Physiology Abdominal Wall

Damage Control Hemorrhage Temporary stenting Packing/tamponade Angio-embolization Recombinant FVIIa Tranexamic acid

Solid Organ Tract Hemorrhage Balloon Tamponade

Total Hepatic Vascular Occlusion

Lap Pad Packing

Lap Pad Packing

Abdominal Packing in Children JPS - 1998 22 patients (age: 6d to 20y) Trauma; tumors; NEC Peri-hepatic: 64% Transfusion: 190 ml/kr All were in shock ( triad )

Abdominal Packing in Children JPS - 1998 Use at primary OP: 68% Control of bleeding: 95% Abscess formation: 32% Survival: 82%

Your Patient is Bleeding Do Something!

Contrast blush on CT

Contrast blush on CT

Angio-Embolization

Splenic Embolization in Injured Children What are the selection criteria?

Proximal vs Distal Splenic Artery Embolization J Trauma 2011 Los Angeles Systematic/meta-analysis in adults (1995-2008) Proximal embolization: - decreases flow - promotes clot formation - reduces infarction - without a higher re-bleed rate.

Pelvic Fracture Hemorrhage

Extraperitoneal Pelvic Packing

Pelvic Compression/Packing

Damage Control Topics When / How / Where? Hemorrhage Physiology Abdominal Wall

Damage Control Physiology Triad Hypothermia Acidosis Coagulopathy (1:1:1)

Coagulopathy of Trauma

Damage Control Triad Effects Pro-coagulant enzymes Fibrinolysis Platelet activation Platelet adhesion The Coagulopathy of Trauma J Trauma Oct 08

Coagulopathy in Pediatric Trauma Traumatic coagulopathy is a complex process that leads to global dysfunction of the endogenous coagulation system resulting in worse outcomes and increased mortality. Although the cause is multifactorial, it is common in severely injured patients and is driven by significant tissue injury and hypoperfusion. Viscoelastic coagulation tests (TEG /ROTEM ) have been established as a rapid and reliable method to assess traumatic coagulopathy and produce a dynamic picture of the entire coagulation process. - Curr Opin Pediatr 2014

Massive Transfusion Protocols Prospective, randomized trials and retrospective analyses support the use of a restrictive packed RBC transfusion policy in most clinical conditions in children. Current transfusion practices for both platelets and coagulant products (e.g., fresh-frozen plasma and recombinant-activated factor VII) are poorly aligned with recommended guidelines. Greater efforts to implement current evidence-based transfusion practices are needed. - Crit Care Med 2014

Tranexamic Acid Anti-fibrinolytic that inhibits the activation of plasminogen to plasmin, thus decreasing the degradation of fibrin. Tranexamic acid has 8X the activity of ε-aminocaproic acid. Benefit in military setting (Arch Surg 2012) No benefit in urban trauma center (J Trauma 2014) Use in pediatric ENT, CV and Ortho surgery No studies in injured children

Recombinant Factor VIIa Dilution/Stored blood products Clot promotion; Activate FXa Effective during hypothermia Thromboelastography (Ped Crit Care Med 2009) Last ditch administration is futile Thrombo-embolic risk?

Safety and Efficacy of rfviia in Refractory Traumatic Hemorrhage - J Trauma 2010 CONTROL randomized Phase 3 Trial 573 pts; 4-8 PRBC in 12 hours End-point futility due to low mortality rfviia reduced blood product use but no affect on mortality

Recombinant Factor VIIa Vick and Islam; JPS 2008 8 children with Grade III-IV injury Used in NOM; all but 1 transfused 75-90 micrograms/kg No adverse thromboembolic events

Damage Control Topics When / How / Where? Physiology Hemorrhage Abdominal Wall

Damage Control Abdominal Wall Temporary expansion Facilitate re-exploration Abdominal compartment syndrome

Temporary Abdominal Wall Closure

Temporary Abdominal Wall Closure

Temporary Abdominal Wall Closure

Temporary Abdominal Wall Closure

Temporary Abdominal Wall Closure

Temporary Abdominal Wall Closure VAC results in lower volume reserve capacity and increased risk of recurrent IAH J Trauma April 2009

Abdominal Compartment Syndrome Sequelae Cardiovascular Pulmonary Renal Occult GI - J Trauma 2009

Abdominal Compartment Syndrome in Children Neville, et al; JPS - 2000 23 patients (NEC, trauma) FiO 2 : 0.87 to 0.67; p<0.01 PIP: 33 to 27; p<0.01 Survival: 65%

Damage Control Summary Emphasis on physiologic/metabolic state Must be employed prior to irreversible shock Systematic, staged, multi-disciplinary approach Represents advanced surgical/trauma care!

Pediatric Trauma in US Leading cause of death in children > 1 year 22,000 deaths/year (age < 14 y) 600,000 hospitalizations/year 1 in 4 children require emergency visit Cost > $5 billion/year